Employment status among non-retired cancer survivors in Japan

European Journal of Cancer Care
H ItoM Murakami

Abstract

Employed cancer patients confront some challenges as they attempt to return to work after treatment. We aimed to identify correlates of return to work for cancer survivors in Japan, with an emphasis on employment status. Participants were 260 patients (aged <65 years) who had received a cancer diagnosis ≥ 1 year previously and who were employed at the time of diagnosis. Participants completed questionnaires at consultations at any Regional Cancer Center Hospitals in Yamagata, Japan between 28 November 2011 and 9 December 2011. Logistic regression analysis was used to identify correlates of return to work. Data cross-tabulation was used to evaluate relationships to workplace and income-changes by employment status. A high proportion of patients (75.8%) had returned to work. Non-regularly employed survivors were less likely to return to work (odds ratio = 5.03; 95% confidence interval, 1.18-21.35). Individuals with poor health, advanced-stage tumours, of advanced age and women were significantly less likely to return to work. Only 52.8% of non-regular employees continued to be employed, and their income decreased by as much as 61.1%. Social and financial support policies should be organised based on more intensive study of employ...Continue Reading

References

Jul 6, 2000·General Hospital Psychiatry·J R Peteet
Jul 12, 2002·Psycho-oncology·Cathy J Bradley, Heather L Bednarek
Mar 22, 2005·Research in Nursing & Health·Heather L Bednarek, Cathy J Bradley
Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mélanie DroletLuc Deschênes
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Reynard R BouknightZhehui Luo
May 15, 2007·Acta Oncologica·T Taskila, M L Lindbohm
May 15, 2007·Acta Oncologica·Saevar Berg GudbergssonAlv A Dahl
Feb 8, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Saevar Berg GudbergssonUNKNOWN NOCWO
Mar 4, 2008·Journal of the National Cancer Institute·Sophie LauzierJean Robert
Mar 20, 2008·British Journal of Cancer·A G E M de BoerF J H van Dijk
Jun 4, 2008·Scandinavian Journal of Public Health·Kathrine CarlsenChristoffer Johansen
Jul 12, 2008·Journal of Occupational and Environmental Medicine·Jennifer A HansenCara H Olsen
Jul 24, 2008·Journal of Cancer Survivorship : Research and Practice·Ziv AmirKaren Luker
Jul 26, 2008·Journal of Cancer Survivorship : Research and Practice·Saevar Berg GudbergssonAlv A Dahl
Aug 20, 2008·Bone Marrow Transplantation·S BieriY Chalandon
Sep 17, 2008·Journal of Cancer Survivorship : Research and Practice·Astri SyseØystein Kravdal
Oct 16, 2008·Breast Cancer Research and Treatment·Eunmi AhnYoung Ho Yun
Feb 2, 2010·Critical Reviews in Oncology/hematology·Anja Mehnert
Jan 3, 2013·European Journal of Cancer Care·P van MuijenA J van der Beek

❮ Previous
Next ❯

Citations

Jul 31, 2016·BMC Cancer·Keiichiro NakamuraYuji Hiramatsu
Jun 26, 2018·Japanese Journal of Clinical Oncology·Haruru KotaniHiroji Iwata
Apr 27, 2019·International Journal of Environmental Research and Public Health·Atsuhiko OtaHiroshi Yatsuya
Dec 22, 2020·Sangyō eiseigaku zasshi = Journal of occupational health·Kenryo OharaMachiko Kawahira
Sep 14, 2021·Work : a Journal of Prevention, Assessment, and Rehabilitation·Yoshiteru AkezakiShinsuke Sugihara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.